Psychiatry & Neurology Doctors in Rolla, MO Accepting Medicare

10 Psychiatry & Neurology doctors found. Showing 1 - 10

Mignon M Makos, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 1050 W 10th St, Rolla, MO 65401 Phone: 573-364-9000    Fax: 816-364-3894

Dr. Sreekant Kodela, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1450 E 10th St, Rolla, MO 65401 Phone: 888-403-1071

Dr. Lirong Zhu, M.D., PH.D. Psychiatry & Neurology - Sleep Medicine Medicare: Accepting Medicare Assignments Practice Location: 1605 Martin Springs Dr, Suite 360b, Rolla, MO 65401 Phone: 573-458-6380    Fax: 573-458-6464

Dr. Shannon Liane Robinson, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1000 W 10th St, Rolla, MO 65401 Phone: 573-364-9000    Fax: 573-202-2484

Dr. Michelle M Hill, DO Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 575b Blues Lake Pkwy, Rolla, MO 65401 Phone: 573-364-2007    Fax: 573-202-2455

Dr. Sasan Moshirzadeh, M.D Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 1050 W 10th St, Rolla, MO 65401 Phone: 573-364-9000    Fax: 573-202-2484

Madeleine A Philpot, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 575 Blues Lake Parkway, Pcrmc Center Clinic, Rolla, MO 65401 Phone: 573-426-2214    Fax: 573-202-2455

Fauzia Iqbal, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 1450 E 10th St, Rolla, MO 65401 Phone: 573-364-7551    Fax: 573-364-4898

Dr. Mallikarjuna Bagewadi Ellur, M.D., Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1000 W 10th St, Rolla, MO 65401 Phone: 573-458-8899

Dr. Shirley Eyman, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 1450 E 10th St, Rolla, MO 65401 Phone: 573-364-7551    Fax: 573-364-4898

News Archive

SAGE Therapeutics obtains $20M Series B financing from two investors

SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat central nervous system (CNS) diseases, today announced a $20 million Series B financing from investors ARCH Venture Partners and Third Rock Ventures, bringing the total raised to $57.8 million since launch in 2011.

Safinamide improves responder rates in fluctuating Parkinson's patients in Phase III study

Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., a pharmaceutical company strongly committed to the respiratory, primary care and CNS therapeutic areas, presented results from SETTLE Phase III study with safinamide at the 17th International Congress of Parkinson's disease and Movement Disorders, taking place from June 16 to 20, 2013, at the Sydney Convention and Exhibition Centre, Sydney, Australia.

Scientists investigate factors that influence choice of abused drugs

Prescription opioid abuse has reached epidemic levels in the past 15 years. Scientists investigating why people favor one drug over another have found that oxycodone and hydrocodone are the drugs of choice for 75% of opioid-dependent individuals.

DiscoGnosis project aims to develop rapid malaria test

An estimated 500 million people become infected with malaria each year. The disease is often lethal - particularly in tropical developing countries with insufficient health care services. The infected suffer from a high fever. As this is also the case with other germs, however, it is important to conduct a rapid and precise analysis to determine the cause of the disease for a successful therapy.

Read more Medical News

› Verified 8 days ago